drugset / Trial / NCT00692055

Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

NCT00692055

Phase 1 Completed 30 enrolled POZEN
RandomizedCrossoverOpen-labelBasic science

Summary

We will evaluate the bioavailability of naproxen 375 mg in two formulations

Timeline

Start
2008-06
Primary completion
2008-07
Completion
2008-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Esomeprazole Small molecule 20 mg
Comparator Naproxen Small molecule 375 mg